MATEON THERAPEUTICS INC 4
4 · MATEON THERAPEUTICS INC · Filed Jan 13, 2017
Insider Transaction Report
Form 4
LOAR MATTHEW M
Chief Financial Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2017-01-12$0.38/sh+350,000$131,250→ 350,000 totalExercise: $0.38Exp: 2027-01-12→ Common Stock (350,000 underlying)
Footnotes (2)
- [F1]Mr. Loar was awarded options to purchase shares of Mateon Therapeutics, Inc. common stock, $0.01 par value per share, pursuant to the Mateon Therapeutics, Inc. 2017 Equity Incentive Plan in connection with his service as Chief Financial Officer.
- [F2]The Options will vest in forty-eight equal monthly installments beginning one month after the grant date.